Article
Muc1 Immunotherapy
1 May 2010
Abstract excerpt
The overexpression and aberrant glycosylation of MUC1 is associated with a wide variety of cancers, making it an ideal target for immunotherapeutic strategies. This review highlights the main avenues of research in this field, focusing on adenocarcinomas, from the preclinical to clinical; the problems and possible solutions associated with each approach; and speculates on the direction of MUC1 immunotherapeutic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
